E-DRUG Archives (by thread)

  • [e-drug] Repackaging medicines in pharmacies (4), Sarah Sellers
  • [e-drug] Repackaging medicines in pharmacies (5), Stein Lyftingsmo
  • [e-drug] PLoS Medicine on Essential Health R&D Treaty, Nicoletta Dentico
  • [e-drug] Inappropriate donations to South East Asia (5), Ghislaine Soulier
  • [e-drug] Training course in Supply Chain Management of HIV/AIDS Medicines&Supplies, Clarisse Audrey Morris
  • [e-drug] GlaxoSmithKline aims to stop ARV reimportation, E-Drug
  • [e-drug] a new essential health R&D treaty, E-Drug
  • [e-drug] GlaxoSmithKline aims to stop ARV reimportation (1), Kevin Outterson
  • [e-drug] Updated International Drug Price Indicator Guide, Julie McFadyen
  • [e-drug] Short Courses in International Health at Heidelberg University, Natascha Petersen
  • [e-drug] Global tobacco treaty enters into force, Leela McCullough
  • [e-drug] GSK aims to stop ARV reimportation (3), Kevin Outterson
  • [e-drug] Use of Maloprim as malaria chemoprophylaxis, Kae Ting Trouilloud
  • [e-drug] FIP launches webpage on Counterfeit Medicines, E-Drug
  • [e-drug] GlaxoSmithKline aims to stop ARV reimportation (2), Akunne Anayo
  • [e-drug] Use of Maloprim as malaria chemoprophylaxis (2), Andy Gray
  • [e-drug] Managing Drug Supply course 2005, Andrew Marshall
  • [e-drug] Book: IP in the context of the WTO TRIPS agreement, Gabriela
  • [e-drug] Vacancy: National Project Manager DFID Nigeria, Suzanne Law
  • [e-drug] Use of Maloprim as malaria chemoprophylaxis (3), Douglas Ball
  • [e-drug] The Lancet - Neonatal Survival Series, Valeria Frighi
  • [e-drug] Biosimilar Compounds, Dr. Majid Cheraghali
  • [e-drug] Myths about hospital formularies persist (5), Francis Juma
  • [e-drug] HealthNet News Special Edition on Neonatal Survival, Leela McCullough
  • [e-drug] Concurrent use of Co-trimoxazole and ACT in children, adenrele koleade
  • [e-drug] BMJ on abstinence and AIDS in Uganda, Valeria Frighi
  • RE: [e-drug] Myths about hospital formularies persist (7), Bernard Van de Wal
  • [e-drug] Use of Paracheck malaria diagnotic, Barbara Neitzert
  • [e-drug] 2005 SEAM Conference -- Targeting Improved Access, Johnson,Keith
  • [e-drug] Concurrent use of Co-trimoxazole and ACT in children (2), FHJansen
  • [e-drug] Glaxo GMP problems in USA; FDA bans distribution, E-Drug
  • [e-drug] Demand for 2 originator ARVs could soon exceed supply, E-Drug
  • [e-drug] Growing Artemisia annua in tropical Africa (6), plantwild
  • [e-drug] joint drug basket experiences in Africa?, Wilbert Bannenberg
  • [e-drug] Dose of artesunate+ amodiaquine, godspower okangba
  • [e-drug] Use of Paracheck malaria diagnostic (2), Dr Stephen Vrede
  • [e-drug] RFI: Good references on Drug Supply Management, Jooste, Miss Jacqui
  • [e-drug] Foreign nations lobbying for patents law, Ellen T HOEN
  • [e-drug] RFI: Good references on Drug Supply Management (2), Kibumba George
  • [e-drug] RFI: Good references on Drug Supply Management (3), Holland,Ross
  • [e-drug] Dose of artesunate and amodiaquine (2), FHJansen
  • [e-drug] IFPMA reaction to R&D Treaty proposal, James Love
  • [e-drug] Medicaid Rarely Ensures Accuracy of Prescription Drug Prices, Joana Ramos
  • [e-drug] RFI: Pharmaco-vigilance, Olutayo Adetokunbo
  • [e-drug] RFI: Pharmaco-vigilance (3), Joseph Serutoke
  • [e-drug] RFI: Pharmaco-vigilance (4), Shanthi Pal
  • [e-drug] Demand for 2 originator ARVs could soon exceed supply (3), Fernando Pascual Martmnez
  • [e-drug] Methylene Blue alternatives?, zahid ghous
  • [e-drug] Medicine prices in Lebanon, Margaret Ewen
  • [e-drug] free text medline searching, E-Drug
  • [e-drug] Letter from UN Envoy HIV AIDS to Indian PM and President, Ellen T HOEN
  • [e-drug] RFI: Good references on Drug Supply Management (4), Carolyn Green
  • [e-drug] Motion for India from the 3rd Francophone Days on HIV/AIDS, Ellen T HOEN
  • [e-drug] E-Learning Course: Management of Medicines in International Health, Tanja Schwering
  • [e-drug] Course on Tropical Medicine, Fondazione de Carneri
  • [e-drug] FT: India's opposition rejects law, Nathan Ford
  • [e-drug] TB Alliance and GSK to Develop New TB Therapies, Sarah Ee
  • [e-drug] AP-groups critical of India on patent laws, Rachel COHEN
  • [e-drug] India designated 16th PEPFAR country, Rachel COHEN
  • [e-drug] Codex and vitamins, Joel Lexchin
  • [e-drug] The Economist: An overdose of bad news, Libby Levison
  • [e-drug] Joint statement Indian NGOs and MSF on passage of Indian patent law, Rachel COHEN
  • [e-drug] Drugs removed from the Canadian market, Joel Lexchin (York)
  • [e-drug] WHO Model List of Essential Medicines and Patents, Hans Hogerzeil
  • [e-drug] New international ARV monographs, Sabine Kopp
  • [e-drug] MSF: Simple & Rapid Diagnostic Tools Key for Fighting TB, Rachel COHEN
  • [e-drug] AIDS-Care-Watch Campaign Launch Announcement, Mathurot Chuladul
  • [e-drug] MSF statement about the new Indian Patent Bill, E-Drug
  • [e-drug] IDA Solutions positions available, Heather Houlihan
  • [e-drug] Drugs removed from the Canadian market (2), Charles Medawar
  • [e-drug] Vitamins, minerals as prescription drugs?, Joel Lexchin
  • [e-drug] Khat use as risk factor for psychotic disorders, E-drug
  • [e-drug] TB: An Old Disease Needs New Cures, Rachel Cohen
  • [e-drug] Cost effectiveness and cost benefit analysis, Abanum Mark
  • [e-drug] FDA efforts to undermine Declaration of Helsinki, Peter Lurie
  • [e-drug] Malaria not rolling back..., Daniel Berman
    • Mail converted by MHonArc 2.6.8